Published in J Signal Transduct on July 14, 2011
α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea. Asian Pac J Trop Biomed (2014) 0.79
Tbl3 regulates cell cycle length during zebrafish development. Dev Biol (2012) 0.76
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell (2005) 17.41
Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science (1990) 5.21
Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell (1995) 4.32
Erythropoietin: structure, control of production, and function. Physiol Rev (1992) 4.24
The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence. Cell (1992) 3.59
Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev (1998) 3.40
TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B. J Biol Chem (2001) 2.65
CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature (2001) 2.47
The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem (1990) 2.03
Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J Biol Chem (1993) 2.02
The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol (2002) 2.02
The Erythropoietin Receptor: Structure, Activation and Intracellular Signal Transduction. Trends Endocrinol Metab (1999) 1.79
Proliferation and maturation of human erythroid progenitors in liquid culture. Blood (1989) 1.78
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia. Blood (2008) 1.72
Protein tyrosine phosphatases in the JAK/STAT pathway. Front Biosci (2008) 1.63
Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex. Proc Natl Acad Sci U S A (1983) 1.60
Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N Engl J Med (1988) 1.56
Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc Natl Acad Sci U S A (1992) 1.55
The role of oxidative stress in hemolytic anemia. Curr Mol Med (2008) 1.51
The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major. Blood (2000) 1.49
Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry (1989) 1.38
Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood (1995) 1.34
Ineffective erythropoiesis and thalassemias. Curr Opin Hematol (2009) 1.34
Perturbations in the erythroid marrow progenitor cell pools may play a role in the augmentation of HbF by 5-azacytidine. Blood (1984) 1.33
Erythropoietin receptor characteristics on primary human erythroid cells. Blood (1991) 1.32
Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia. J Clin Invest (2005) 1.26
Induction of gamma-globin by histone deacetylase inhibitors. Blood (1997) 1.26
The biophysics of sickle cell hydroxyurea therapy. Science (1995) 1.25
Haemoglobin and red cell enzyme changes in juvenile myeloid leukaemia. Br Med J (1968) 1.23
A sustained and pancellular reversal of gamma-globin gene silencing in adult human erythroid precursor cells. Blood (2004) 1.18
Stimulation of fetal hemoglobin synthesis by erythropoietin in baboons. N Engl J Med (1987) 1.15
Activation of mitogen-activated protein (MAP) kinase pathway by pervanadate, a potent inhibitor of tyrosine phosphatases. J Biol Chem (1996) 1.14
Fetal erythropoiesis in stress hematopoiesis. Exp Hematol (1979) 1.14
The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor. Eur J Biochem (1997) 1.09
Anemia in renal disease: diagnosis and management. Blood Rev (2009) 1.06
The role of SHIP in cytokine-induced signaling. Rev Physiol Biochem Pharmacol (2003) 1.06
Hemin-induced acceleration of hemoglobin production in immature cultured erythroid cells: preferential enhancement of fetal hemoglobin. Blood (1995) 1.02
Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab (1995) 1.01
SCF induces gamma-globin gene expression by regulating downstream transcription factor COUP-TFII. Blood (2009) 1.00
5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin. J Clin Invest (1985) 1.00
Mild sickle-cell anaemia in Iran associated with high levels of fetal haemoglobin. J Med Genet (1977) 0.99
Novel treatment options in the severe beta-globin disorders. Br J Haematol (1995) 0.99
Genetic causes of erythrocytosis and the oxygen-sensing pathway. Blood Rev (2008) 0.97
Solubilization of hemoglobin S by other hemoglobins. Proc Natl Acad Sci U S A (1980) 0.95
c-kit ligand reactivates fetal hemoglobin synthesis in serum-free culture of stringently purified normal adult burst-forming unit-erythroid. Blood (1993) 0.92
Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases. Biochem J (1997) 0.92
Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis. J Clin Invest (1985) 0.91
In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol Cell Biochem (1996) 0.91
Reversing the hemoglobin switch. N Engl J Med (2010) 0.90
Oligomerization and scaffolding functions of the erythropoietin receptor cytoplasmic tail. J Biol Chem (1999) 0.89
Activation of STAT factors by prolactin, interferon-gamma, growth hormones, and a tyrosine phosphatase inhibitor in rabbit primary mammary epithelial cells. J Biol Chem (1995) 0.86
The SH2 inositol 5-phosphatase Ship1 is recruited in an SH2-dependent manner to the erythropoietin receptor. J Biol Chem (2000) 0.86
Adult and neonatal patterns of human globin gene expression are recapitulated in liquid cultures. Exp Hematol (1992) 0.86
Hydroxyurea and erythropoietin therapy in sickle cell anemia. Semin Oncol (1992) 0.85
Relationship of haemoglobin F and alpha thalassaemia to severity of sickle-cell anaemia in the Eastern Province of Saudi Arabia. Ann Trop Paediatr (1986) 0.84
Erythropoietin activity in the serum of beta thalassemic patients. Scand J Haematol (1986) 0.83
Influence of steel factor on hemoglobin synthesis in sickle cell disease. Blood (1992) 0.83
Pervanadate simulates the effects of interleukin-2 (IL-2) in human T cells and provides evidence for the activation of two distinct tyrosine kinase pathways by IL-2. J Biol Chem (1994) 0.83
Erythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly-devised quantitative flow-cytometric assay. Br J Haematol (1997) 0.81
Protein kinases and phosphatases are involved in erythropoietin-mediated signal transduction. Exp Hematol (1992) 0.80
Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells. Blood (2000) 0.80
Trial of recombinant human erythropoietin: three patients with thalassemia intermedia. Blood (1992) 0.80
Modulation of HBF production by erythropoietin. Prog Clin Biol Res (1989) 0.79
Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial. Blood (1991) 0.79
Reducing erythropoietin in cultures of human erythroid precursors elevates the proportion of fetal haemoglobin. Br J Haematol (1994) 0.78
Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. J Matern Fetal Med (1999) 0.78
Transcriptional upregulation of gamma-globin by phenylbutyrate and analogous aromatic fatty acids. Biochem Pharmacol (1996) 0.76
Vanadate elevates fetal hemoglobin in human erythroid precursors by inhibiting cell maturation. Exp Biol Med (Maywood) (2007) 0.76
Recombinant human erythropoietin therapy in a transfusion-dependent beta-thalassemia major patient. Ann Hematol (2001) 0.76